University South Carolina Orthopedic Surgery 2 Medical Park Rd STE L9, Columbia, SC 29203 8034346812 (phone), 8034347306 (fax)
University South Carolina Specialty Clinics Orthopaedics 300 Palmetto Health Pkwy STE 201, Columbia, SC 29212 8034346812 (phone), 8034347306 (fax)
Education:
Medical School University of Maryland School of Medicine Graduated: 2005
Procedures:
Occupational Therapy Evaluation Shoulder Surgery Spinal Cord Surgery Spinal Fusion Spinal Surgery Arthrocentesis Hallux Valgus Repair Hip Replacement Hip/Femur Fractures and Dislocations Knee Arthroscopy Lower Arm/Elbow/Wrist Fractures and Dislocations Lower Leg/Ankle Fractures and Dislocations Wound Care
Conditions:
Intervertebral Disc Degeneration Spinal Stenosis Fractures, Dislocations, Derangement, and Sprains Internal Derangement of Knee Cartilage Osteoarthritis
Languages:
English
Description:
Dr. Grabowski graduated from the University of Maryland School of Medicine in 2005. He works in Columbia, SC and 1 other location and specializes in Orthopaedic Surgery. Dr. Grabowski is affiliated with Palmetto Health Baptist, Palmetto Health Baptist Parkridge and Palmetto Health Richland Hospital.
Gregory J Grabowski PC 11711 NE 12 St STE 1B, Bellevue, WA 98005 4254531598 (phone), 4254500029 (fax)
Podiatrists Physicians & Surgeons 1101 Madison St STE 1120, Seattle, WA 98104 2064470302 (phone)
Procedures:
Hallux Valgus Repair Arthrocentesis
Conditions:
Hallux Valgus Plantar Fascitis Tinea Pedis
Languages:
English Spanish Vietnamese
Description:
Dr. Grabowski works in Bellevue, WA and 1 other location and specializes in Podiatric Medicine. Dr. Grabowski is affiliated with Overlake Hospital Medical Center and Swedish Medical Center - First Hill.
Us Patents
Lysosomal Acid Lipase Therapy For Nafld And Related Diseases
- Cincinnati OH, US Gregory A. Grabowski - Wheat Ridge CO, US
International Classification:
A61K 38/46 A61K 9/00 A61K 45/06
Abstract:
The present invention comprises methods and compositions for the treatment or alleviation of NAFLD (non-alcoholic fatty liver disease) and those conditions associated with NAFLD, including fatty liver disease, nonalcoholic steatohepatitis (NASH) and cirrhosis through the use of pharmaceutical formulations of lysosomal acid lipase or related proteins and/or polypeptides. This invention is also directed to a combination therapy treatment for treating The Metabolic Syndrome. As part of a combination therapy regime for the treatment of The Metabolic Syndrome, pharmaceutical formulations of lysosomal acid lipase or related proteins and/or polypeptides are used as part of the combination therapy regime for treating NAFLD (and NASH), which comprises one of the conditions constituting The Metabolic Syndrome,
Isbn (Books And Publications)
Gaucher Disease, a Century of Delineation and Research: Proceedings of the First International Symposium on Gaucher Disease, Held in New York City, July 22-24, 1981